SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-18-000920
Filing Date
2018-08-27
Accepted
2018-08-27 16:43:17
Documents
4
Period of Report
2018-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k082718_8k.htm 8-K 16595
2 EXHIBIT 99.1 PRESS RELEASE f8k082718_ex99z1.htm EX-99.1 11453
3 IMAGE f8k0827188k1.jpg GRAPHIC 51378
4 IMAGE f8k082718ex99z11.gif GRAPHIC 43
  Complete submission text file 0001078782-18-000920.txt   99881
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 181039330
SIC: 2834 Pharmaceutical Preparations